Literature DB >> 15108806

New roles for the RB tumor suppressor protein.

Huiping Liu1, Benjamin Dibling, Benjamin Spike, Alexandra Dirlam, Kay Macleod.   

Abstract

For a gene whose existence was first postulated in 1971, was cloned in 1986 and whose functions have been extensively characterized ever since, you might be inclined to think there was not much new to report regarding the retinoblastoma tumor suppressor gene (RB)--but you would be wrong to make such an assumption. RB is still piquing our interest with several activities defined over the past year that reveal new and exciting roles for this key tumor suppressor gene. These functions include regulation of senescence through specific gene silencing mechanisms, control of developmental processes in extra-embryonic tissues, maintaining tissue homeostasis and determining survival responses to chemotherapy.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15108806     DOI: 10.1016/j.gde.2003.11.005

Source DB:  PubMed          Journal:  Curr Opin Genet Dev        ISSN: 0959-437X            Impact factor:   5.578


  20 in total

1.  Rb/E2F regulates expression of neogenin during neuronal migration.

Authors:  Matthew G Andrusiak; Kelly A McClellan; Delphie Dugal-Tessier; Lisa M Julian; Sonia P Rodrigues; David S Park; Timothy E Kennedy; Ruth S Slack
Journal:  Mol Cell Biol       Date:  2010-11-08       Impact factor: 4.272

Review 2.  Biology and management of pancreatic cancer.

Authors:  Paula Ghaneh; Eithne Costello; John P Neoptolemos
Journal:  Gut       Date:  2007-08       Impact factor: 23.059

3.  Interaction among Rb/p16, Rb/E2F1 and HDAC1 proteins in gallbladder carcinoma.

Authors:  Xin Wang; Kai Huang; Lining Xu
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2009-12-29

Review 4.  Minireview: The roles of small RNA pathways in reproductive medicine.

Authors:  Shannon M Hawkins; Gregory M Buchold; Martin M Matzuk
Journal:  Mol Endocrinol       Date:  2011-05-05

5.  Retinoblastoma protein induction by HIV viremia or CCR5 in monocytes exposed to HIV-1 mediates protection from activation-induced apoptosis: ex vivo and in vitro study.

Authors:  Bethsebah Gekonge; Andrea D Raymond; Xiangfan Yin; Jay Kostman; Karam Mounzer; Ronald G Collman; Louise Showe; Luis J Montaner
Journal:  J Leukoc Biol       Date:  2012-06-13       Impact factor: 4.962

Review 6.  Exploring cancer metabolism using stable isotope-resolved metabolomics (SIRM).

Authors:  Ronald C Bruntz; Andrew N Lane; Richard M Higashi; Teresa W-M Fan
Journal:  J Biol Chem       Date:  2017-06-07       Impact factor: 5.157

Review 7.  Tailoring to RB: tumour suppressor status and therapeutic response.

Authors:  Erik S Knudsen; Karen E Knudsen
Journal:  Nat Rev Cancer       Date:  2008-09       Impact factor: 60.716

8.  p19Arf represses platelet-derived growth factor receptor β by transcriptional and posttranscriptional mechanisms.

Authors:  Ryan C Widau; Yanbin Zheng; Caroline Y Sung; Anna Zelivianskaia; Lauren E Roach; Karen M Bachmeyer; Tatiana Abramova; Aurelie Desgardin; Andrew Rosner; John M Cunningham; Stephen X Skapek
Journal:  Mol Cell Biol       Date:  2012-08-20       Impact factor: 4.272

9.  Repression of Ah receptor and induction of transforming growth factor-beta genes in DEN-induced mouse liver tumors.

Authors:  Li Peng; Christopher N Mayhew; Michael Schnekenburger; Erik S Knudsen; Alvaro Puga
Journal:  Toxicology       Date:  2008-01-16       Impact factor: 4.221

10.  Cooperative activation of tissue-specific genes by pRB and E2F1.

Authors:  Stephen Flowers; Fuhua Xu; Elizabeth Moran
Journal:  Cancer Res       Date:  2013-01-22       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.